- Home
- MRAM vs COYA Comparison
MRAM vs COYA Comparison
Compare MRAM & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- COYA
- Stock Information
- Founded
- MRAM 2008
- COYA 2020
- Country
- MRAM United States
- COYA United States
- Employees
- MRAM N/A
- COYA N/A
- Industry
- MRAM Semiconductors
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- MRAM Technology
- COYA Health Care
- Exchange
- MRAM Nasdaq
- COYA Nasdaq
- Market Cap
- MRAM 114.4M
- COYA 99.8M
- IPO Year
- MRAM 2016
- COYA 2022
- Fundamental
- Price
- MRAM $6.75
- COYA $6.13
- Analyst Decision
- MRAM Strong Buy
- COYA Strong Buy
- Analyst Count
- MRAM 1
- COYA 4
- Target Price
- MRAM $8.00
- COYA $16.50
- AVG Volume (30 Days)
- MRAM 216.5K
- COYA 71.0K
- Earning Date
- MRAM 07-30-2025
- COYA 08-11-2025
- Dividend Yield
- MRAM N/A
- COYA N/A
- EPS Growth
- MRAM N/A
- COYA N/A
- EPS
- MRAM N/A
- COYA N/A
- Revenue
- MRAM $49,110,000.00
- COYA $3,685,107.00
- Revenue This Year
- MRAM $9.48
- COYA $106.97
- Revenue Next Year
- MRAM $12.85
- COYA N/A
- P/E Ratio
- MRAM N/A
- COYA N/A
- Revenue Growth
- MRAM N/A
- COYA N/A
- 52 Week Low
- MRAM $4.34
- COYA $4.65
- 52 Week High
- MRAM $7.02
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- MRAM 62.00
- COYA 57.80
- Support Level
- MRAM $6.70
- COYA $5.97
- Resistance Level
- MRAM $6.94
- COYA $6.45
- Average True Range (ATR)
- MRAM 0.24
- COYA 0.38
- MACD
- MRAM 0.03
- COYA 0.06
- Stochastic Oscillator
- MRAM 74.30
- COYA 69.05
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.